Logo image of ERA.PA

ERAMET (ERA.PA) Stock Fundamental Analysis

EPA:ERA - FR0000131757 - Common Stock

47.92 EUR
-0.08 (-0.17%)
Last: 9/10/2025, 5:35:30 PM
Fundamental Rating

3

Overall ERA gets a fundamental rating of 3 out of 10. We evaluated ERA against 38 industry peers in the Metals & Mining industry. Both the profitability and financial health of ERA have multiple concerns. ERA is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

ERA had negative earnings in the past year.
In the past year ERA has reported a negative cash flow from operations.
ERA had positive earnings in 4 of the past 5 years.
Of the past 5 years ERA 4 years had a positive operating cash flow.
ERA.PA Yearly Net Income VS EBIT VS OCF VS FCFERA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

1.2 Ratios

ERA has a worse Return On Assets (-1.58%) than 63.16% of its industry peers.
ERA's Return On Equity of -9.29% is on the low side compared to the rest of the industry. ERA is outperformed by 71.05% of its industry peers.
ERA has a worse Return On Invested Capital (0.84%) than 65.79% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ERA is in line with the industry average of 8.12%.
The last Return On Invested Capital (0.84%) for ERA is well below the 3 year average (7.61%), which needs to be investigated, but indicates that ERA had better years and this may not be a problem.
Industry RankSector Rank
ROA -1.58%
ROE -9.29%
ROIC 0.84%
ROA(3y)4.1%
ROA(5y)1.33%
ROE(3y)16.44%
ROE(5y)-1.91%
ROIC(3y)7.61%
ROIC(5y)8.07%
ERA.PA Yearly ROA, ROE, ROICERA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60 -80

1.3 Margins

In the last couple of years the Profit Margin of ERA has declined.
The Operating Margin of ERA (1.91%) is worse than 65.79% of its industry peers.
ERA's Operating Margin has declined in the last couple of years.
ERA has a better Gross Margin (68.15%) than 94.74% of its industry peers.
In the last couple of years the Gross Margin of ERA has grown nicely.
Industry RankSector Rank
OM 1.91%
PM (TTM) N/A
GM 68.15%
OM growth 3Y-46.5%
OM growth 5Y-18.83%
PM growth 3Y-61.12%
PM growth 5YN/A
GM growth 3Y-3.21%
GM growth 5Y23.96%
ERA.PA Yearly Profit, Operating, Gross MarginsERA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ERA is destroying value.
The number of shares outstanding for ERA has been increased compared to 1 year ago.
ERA has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ERA has an improved debt to assets ratio.
ERA.PA Yearly Shares OutstandingERA.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ERA.PA Yearly Total Debt VS Total AssetsERA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

ERA has an Altman-Z score of 1.07. This is a bad value and indicates that ERA is not financially healthy and even has some risk of bankruptcy.
ERA has a worse Altman-Z score (1.07) than 71.05% of its industry peers.
ERA has a Debt/Equity ratio of 2.03. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of ERA (2.03) is worse than 86.84% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.03
Debt/FCF N/A
Altman-Z 1.07
ROIC/WACC0.09
WACC9.15%
ERA.PA Yearly LT Debt VS Equity VS FCFERA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

ERA has a Current Ratio of 1.54. This is a normal value and indicates that ERA is financially healthy and should not expect problems in meeting its short term obligations.
ERA has a Current ratio of 1.54. This is in the lower half of the industry: ERA underperforms 65.79% of its industry peers.
A Quick Ratio of 1.06 indicates that ERA should not have too much problems paying its short term obligations.
ERA has a Quick ratio (1.06) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.54
Quick Ratio 1.06
ERA.PA Yearly Current Assets VS Current LiabilitesERA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

4

3. Growth

3.1 Past

ERA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -221.18%.
ERA shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -64.00% yearly.
The Revenue has decreased by -6.91% in the past year.
The Revenue has been decreasing by -4.39% on average over the past years.
EPS 1Y (TTM)-221.18%
EPS 3Y-64%
EPS 5YN/A
EPS Q2Q%-268.75%
Revenue 1Y (TTM)-6.91%
Revenue growth 3Y-7.18%
Revenue growth 5Y-4.39%
Sales Q2Q%-3.31%

3.2 Future

Based on estimates for the next years, ERA will show a very strong growth in Earnings Per Share. The EPS will grow by 29.34% on average per year.
The Revenue is expected to grow by 8.02% on average over the next years. This is quite good.
EPS Next Y-274.73%
EPS Next 2Y-2.62%
EPS Next 3Y29.34%
EPS Next 5YN/A
Revenue Next Year6.82%
Revenue Next 2Y7.82%
Revenue Next 3Y8.02%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ERA.PA Yearly Revenue VS EstimatesERA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B 5B
ERA.PA Yearly EPS VS EstimatesERA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 20 30

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ERA. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 12.04 indicates a correct valuation of ERA.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ERA indicates a somewhat cheap valuation: ERA is cheaper than 60.53% of the companies listed in the same industry.
ERA is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.59, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 12.04
ERA.PA Price Earnings VS Forward Price EarningsERA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ERA is valued a bit more expensive than the industry average as 65.79% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.07
ERA.PA Per share dataERA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80 100

4.3 Compensation for Growth

A more expensive valuation may be justified as ERA's earnings are expected to grow with 29.34% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.62%
EPS Next 3Y29.34%

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.81%, ERA has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.95, ERA pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.46, ERA has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.81%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
ERA.PA Yearly Dividends per shareERA.PA Yearly Dividends per shareYearly Dividends per share 2019 2022 2023 2024 2025 1 2 3

5.3 Sustainability

ERA has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-44.33%
EPS Next 2Y-2.62%
EPS Next 3Y29.34%
ERA.PA Yearly Income VS Free CF VS DividendERA.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M

ERAMET

EPA:ERA (9/10/2025, 5:35:30 PM)

47.92

-0.08 (-0.17%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)07-30 2025-07-30
Earnings (Next)10-30 2025-10-30
Inst Owners11.85%
Inst Owner ChangeN/A
Ins Owners0.17%
Ins Owner ChangeN/A
Market Cap1.38B
Analysts52.73
Price Target53.24 (11.1%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.81%
Yearly Dividend1.51
Dividend Growth(5Y)N/A
DP-44.33%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-10.51%
PT rev (3m)-17.36%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-513.67%
EPS NY rev (3m)-513.67%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.12%
Revenue NY rev (3m)1.38%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 12.04
P/S 0.48
P/FCF N/A
P/OCF N/A
P/B 1.32
P/tB 2.55
EV/EBITDA 14.07
EPS(TTM)-3.44
EYN/A
EPS(NY)3.98
Fwd EY8.3%
FCF(TTM)-25.76
FCFYN/A
OCF(TTM)-4.59
OCFYN/A
SpS100.31
BVpS36.3
TBVpS18.78
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.58%
ROE -9.29%
ROCE 1.16%
ROIC 0.84%
ROICexc 0.99%
ROICexgc 1.13%
OM 1.91%
PM (TTM) N/A
GM 68.15%
FCFM N/A
ROA(3y)4.1%
ROA(5y)1.33%
ROE(3y)16.44%
ROE(5y)-1.91%
ROIC(3y)7.61%
ROIC(5y)8.07%
ROICexc(3y)11.46%
ROICexc(5y)11.88%
ROICexgc(3y)13.48%
ROICexgc(5y)14.02%
ROCE(3y)10.76%
ROCE(5y)11.32%
ROICexcg growth 3Y-56.22%
ROICexcg growth 5Y-25.38%
ROICexc growth 3Y-55.33%
ROICexc growth 5Y-24.94%
OM growth 3Y-46.5%
OM growth 5Y-18.83%
PM growth 3Y-61.12%
PM growth 5YN/A
GM growth 3Y-3.21%
GM growth 5Y23.96%
F-Score2
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 2.03
Debt/FCF N/A
Debt/EBITDA 10.29
Cap/Depr 403.31%
Cap/Sales 21.11%
Interest Coverage 0.34
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.54
Quick Ratio 1.06
Altman-Z 1.07
F-Score2
WACC9.15%
ROIC/WACC0.09
Cap/Depr(3y)260.42%
Cap/Depr(5y)209.27%
Cap/Sales(3y)18.57%
Cap/Sales(5y)15.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-221.18%
EPS 3Y-64%
EPS 5YN/A
EPS Q2Q%-268.75%
EPS Next Y-274.73%
EPS Next 2Y-2.62%
EPS Next 3Y29.34%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.91%
Revenue growth 3Y-7.18%
Revenue growth 5Y-4.39%
Sales Q2Q%-3.31%
Revenue Next Year6.82%
Revenue Next 2Y7.82%
Revenue Next 3Y8.02%
Revenue Next 5YN/A
EBIT growth 1Y-51.75%
EBIT growth 3Y-50.34%
EBIT growth 5Y-22.39%
EBIT Next Year104.71%
EBIT Next 3Y37.27%
EBIT Next 5YN/A
FCF growth 1Y-850%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-121.46%
OCF growth 3YN/A
OCF growth 5YN/A